NEW YORK (GenomeWeb) – Genetic variants in the PCSK9 gene have the same effect on cardiovascular disease and diabetes risk as variants within the HMGCR gene, which encodes the target of lipid-lowering statins.

According to an international team of researchers, this suggests that therapies targeting PCSK9 should have similar effects as statins on cardiovascular events, but with the same potential risk of developing diabetes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.